These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 7184383

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62. [Endoscopic administration of OK-432 in gastric cancer].
    Inbe A, Sumii K, Haruma K, Uemura N, Tari A, Yoshihara M, Tokutomi T, Inaba Y, Sekito M, Ogoshi H.
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):514-9. PubMed ID: 3954375
    [Abstract] [Full Text] [Related]

  • 63. [Evaluation of various administration routes of the streptococcal preparation, OK-432, with regard to their in vivo effect by lymphocytes proliferation assay].
    Kimura Y, Toki H, Okabe K, Fujii M, Tamai M.
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):95-100. PubMed ID: 3942400
    [Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67. OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.
    Ujiie T.
    Jpn J Exp Med; 1987 Apr; 57(2):103-15. PubMed ID: 3499533
    [Abstract] [Full Text] [Related]

  • 68. [A case of bronchial carcinoma showing regression upon intratumoral administration of OK-432].
    Onodera A, Miura K, Sasaki M, Sugiyama N, Kurokawa H, Shioya T, Kanazawa T.
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):341-4. PubMed ID: 3341793
    [Abstract] [Full Text] [Related]

  • 69. Mechanism of action of a streptococcal preparation (OK-432) in prevention of autoimmune diabetes in NOD mice. Suppression of generation of effector cells for pancreatic B cell destruction.
    Shintani S, Satoh J, Seino H, Goto Y, Toyota T.
    J Immunol; 1990 Jan 01; 144(1):136-41. PubMed ID: 2295787
    [Abstract] [Full Text] [Related]

  • 70. [Production of a cytotoxic factor in mouse peritoneal fluid by OK-432, a streptococcal preparation].
    Yamamoto A, Nagamuta M, Usami H, Sugawara Y, Watanabe N, Niitsu Y, Urushizaki I.
    Gan To Kagaku Ryoho; 1986 May 01; 13(5):1905-10. PubMed ID: 3707150
    [Abstract] [Full Text] [Related]

  • 71. [Experimental study of oral administration of streptococcal preparation "OK-432". The 6th report: its effect on in vivo anti-tumor immunity of the mice with transplanted cecal tumor].
    Tsuchitani T, Kodama H, Tobe T, Nio Y, Kan N, Inamoto T, Ohgaki K.
    Nihon Gan Chiryo Gakkai Shi; 1985 Apr 20; 20(3):609-17. PubMed ID: 2932509
    [No Abstract] [Full Text] [Related]

  • 72. [Effect of intra-thoracic administration of an immune modulator (OK-432) with anti-cancer drugs (ADR and MMC)].
    Hattori H, Mikuriya S, Mamiya T, Hatano K, Shiina T, Yamada T.
    Gan No Rinsho; 1988 Jun 20; 34(7):851-6. PubMed ID: 3135423
    [Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. Effects of intraperitoneal administration of OK-432 for patients with advanced cancer.
    Toge T, Yamada H, Aratani K, Kameda A, Kuroi K, Hisamatsu K, Hattori T.
    Jpn J Surg; 1985 Jul 20; 15(4):260-5. PubMed ID: 2932585
    [Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. Inhibition of tumor growth in vivo and in vitro by macrophages from rats treated with a streptococcal preparation, OK-432.
    Ishii Y, Yamaoka H, Toh K, Kikuchi K.
    Gan; 1976 Feb 20; 67(1):115-9. PubMed ID: 773733
    [Abstract] [Full Text] [Related]

  • 78. Combination therapy of radiation and immunomodulators in the treatment of MM46 tumor transplanted in C3H/He mice.
    Miyaji C, Ogawa Y, Imajo Y, Imanaka K, Kimura S.
    Oncology; 1983 Feb 20; 40(2):115-9. PubMed ID: 6828288
    [Abstract] [Full Text] [Related]

  • 79. Potential advantages in therapeutic index of OK-432 ointment to abdominal skin over systemic applied in a mouse model.
    Matsuoka H, Yano K, Wasasugi H, Seo Y, Saito T, Tomoda H.
    Cancer Lett; 1996 Mar 19; 101(1):15-20. PubMed ID: 8625276
    [Abstract] [Full Text] [Related]

  • 80. Induction of endogenous tumor necrosis factor by OK-432 in ovarian cancer patients with ascites.
    Mori H, Itoh N, Yamada Y, Tamaya T.
    Biotherapy; 1989 Mar 19; 1(3):123-31. PubMed ID: 2518374
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.